Publication | Open Access
Efficacy and safety of tofacitinib in the treatment of ulcerative colitis: real-life experience in Andalusia
13
Citations
17
References
2022
Year
tofacitinib has a demonstrated efficacy in clinical practice to induce and maintain clinical response in treatment-refractory UC patients, with an acceptable safety profile.
| Year | Citations | |
|---|---|---|
Page 1
Page 1